Search

everythinglearnresearchcommunity

for

Search:↓

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Minoxidil works better for female hair loss than alfatradiol, both safe.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.